In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 127 for your search:
Drug:  amifostine trihydrate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: RNSMC-AM9702, ALZA-RNSMC-AM9702, NCI-V98-1390, NCT00003252

2.

Phase: Phase IV
Type: Supportive care
Status: Temporarily closed
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: SUN-2011-DP, NCT01288625

3.

Phase: Phase III, Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 to physiologic 74
Sponsor: NCI
Protocol IDs: UPCC-00-A-0465, NCI-T87-0232

4.

Phase: Phase III, Phase I
Type: Supportive care, Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: AECM-8908198, NCI-V92-0084

5.

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: USB-WR-38, NCI-V96-1083

6.

Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: UCMC-971163, ALZA-UCMC-971163, NCI-V97-1330

7.

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-9801, CDR0000066260, NCT00003313

8.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 21 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: BOSTON-VAMC-523, ALZA-97-047-ii, NCI-V98-1422

9.

Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-1686

10.

Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CLB-9160, CALGB-9160

11.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000285700, GOG-0192, NCT00058071

12.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: NCI, Other
Protocol IDs: 2004.00, NCI-2009-01543, FHCRC-2004.00, 6004, MEDIMMUNE-FHCRC-2004.00, NCT00217438

13.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and under
Sponsor: NCI, Other
Protocol IDs: ARAR0331, NCI-2009-00412, COG-ARAR0331, CDR0000454849, U10CA098543, NCT00274937

14.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NU 97CC4, NCI-G99-1633, NCT00004166

15.

Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Closed
Age: Over 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: UKMC-96BMT59, ALZA-UKMC-96BMT59, NCI-V97-1332

16.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-97076, ALZA-97-013-ii, NCI-G97-1338

17.

Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 65 and under
Sponsor: Other
Protocol IDs: 8433, UCCRC-8433, ALZA-97-005-ii, NCI-V97-1357, NCT00003136

18.

Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: UARIZ-HSC-97116, ALZA-UARIZ-HSC-97116, NCI-V98-1371

19.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000066028, MGH-M7-20, ALZA-97-024-ii, NCI-V98-1384, NCT00003193

20.

Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000066087, P30CA016042, UCLA-HSPC-970304601B, ALZA-UCLA-HSPC-970304601B, NCI-G98-1390, NCT00003225

21.

Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: UIC-H-97-783, ALZA-UIC-H-97-783, NCI-V98-1389, NCT00003251

22.

Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 14 to 70
Sponsor: Other
Protocol IDs: UKMC-97BMT72, CDR0000066448, ALZA-UKMC-97BMT72, NCI-V98-1455, NCT00003425

23.

Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: UMIAMI-88191, SCCC-1988007, ALZA-97-052-ii, BHM-98-32, NCI-V98-1474, SCCC-97098, NCT00003582

24.

Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068021, NCCTG-N9923, N9923, NCT00006012

25.

Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-0116, CDR0000068472, RTOG-C-0116, NCT00012012
1     
New Search